AFT Pharmaceuticals, Ltd.   Report issue

For profit Phase 3
Founded: Takapuna New Zealand (1997)
Status: No NME R&D (1997)

Organization Overview

First Clinical Trial
2010
NCT01104844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

AFT Pharmaceuticals, Ltd.

Active Ingredients

Drugs in Phase 3 Trials (2)

acetaminophen (tylenol) (5 trials)

ibuprofen (motrin) (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 3)

Pain, Postoperative (Phase 3)

Toothache (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 2